Mentoring in Drug Abuse and Dual Diagnosis Research

药物滥用和双重诊断研究的指导

• 批准号: 7675469
• 负责人: Roger D. Weiss
• 金额: $ 17.44万
• 依托单位: MCLEAN HOSPITAL
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-10 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7675469
• 关键词: Alcohols; Area; Award; Behavior Therapy; Bipolar Disorder; Brain imaging; Clinical; Clinical Trials Network; Cocaine; Dependence; Diagnosis; Doctor of Medicine; Drug abuse; Evaluation; Funding; Grant; Group Therapy; Hospitals; Individual; Lead; Learning; Massachusetts; Mentors; Mid-Career Clinical Scientist Award (K24); Modeling; National Institute of Drug Abuse; National Institute on Alcohol Abuse and Alcoholism; New England; Opioid Analgesics; Pain; Patients; Pharmaceutical Preparations; Pharmacotherapy; Principal Investigator; Psychiatry; Research; Research Personnel; Services; Site; Substance Addiction; Substance abuse problem; Time; Training; career; chronic pain; dual diagnosis; improved; medical schools; next generation; patient oriented; patient oriented research; professor; programs; self help; skills; statistics; treatment program

DESCRIPTION (provided by applicant): This is an application for a K24 Mid-Career Investigator Award in Patient-Oriented Research for Roger Weiss, M.D. Dr. Weiss is Professor of Psychiatry at Harvard Medical School and Clinical Director of the Alcohol and Drug Abuse Treatment Program at McLean Hospital, Belmont, Massachusetts. Dr. Weiss has devoted his career to patient-oriented drug abuse research. He has had continuous NIDA support since 1989, and has successfully mentored individuals who have become independent, nationally known investigators. His research has focused on the evaluation and treatment of 1) cocaine-dependent patients and 2) substance-dependent patients with co-occurring psychiatric illness. He has studied the integration of different models of treatment (i.e., psychiatric with substance abuse approaches, pharmacotherapy with behavioral therapy, professional treatment with self-help approaches) for drug-dependent and dually diagnosed patients. The primary aim of this award is to enable Dr. Weiss to expand his mentoring capacity while continuing to engage in this program of research. In recent years, Dr. Weiss has mentored an increasing number of junior investigators from McLean Hospital and elsewhere. Much of his current mentoring takes place in the context of his own projects. A K24 Award would enable him to 1) spend more time with his mentees; 2) mentor junior investigators outside the confines of his own projects, in the service of helping them to develop independent investigative careers in patient-oriented research; and 3) take on additional mentees that he currently cannot accommodate. Mentoring will take place in the context of three NIH-funded projects on which Dr. Weiss is Principal Investigator: 1) the NIDA Clinical Trials Network, in which he is PI of the Northern New England Node and Lead Investigator of a multi-site study of treatments for opioid analgesic dependence; 2) his NIDA-funded R01 study of group therapy for patients with bipolar disorder and substance dependence; and 3) the multi-site NIAAA COMBINE study, in which he is PI of the Harvard site. As part of the K24 Award, Dr. Weiss will receive additional training in the areas of 1) chronic pain, 2) brain imaging, and 3) statistics, which will simultaneously strengthen his own research skills and improve his mentoring abilities.

描述（由申请人提供）：这是医学博士罗杰·韦斯 (Roger Weiss) 申请 K24 职业生涯中期研究员奖的以患者为导向的研究奖。韦斯博士是哈佛医学院精神病学教授兼酒精和药物滥用治疗临床主任马萨诸塞州贝尔蒙特麦克莱恩医院的项目。韦斯博士将其职业生涯奉献给以患者为导向的药物滥用研究。自 1989 年以来，他一直得到 NIDA 的支持，并成功指导了一些人成为独立的、全国知名的调查员。他的研究重点是评估和治疗 1) 可卡因依赖患者和 2) 伴有精神疾病的物质依赖患者。他研究了针对药物依赖和双重诊断患者的不同治疗模式的整合（即精神治疗与药物滥用方法、药物治疗与行为治疗、专业治疗与自助方法）。该奖项的主要目的是使韦斯博士能够在继续从事该研究计划的同时扩大他的指导能力。近年来，韦斯博士指导了越来越多来自麦克莱恩医院和其他地方的初级研究人员。他目前的大部分指导都是在他自己的项目背景下进行的。 K24 奖将使他能够 1）花更多的时间与他的学员在一起； 2）在自己的项目范围之外指导初级研究人员，帮助他们在以患者为导向的研究中发展独立的研究生涯； 3) 接纳他目前无法容纳的其他学员。 Weiss 博士担任首席研究员的三个 NIH 资助项目将提供指导：1) NIDA 临床试验网络，其中他是新英格兰北部节点的 PI 和多中心研究的首席研究员阿片类镇痛依赖的治疗方法； 2) 他的 NIDA 资助的 R01 研究，针对双相情感障碍和物质依赖患者进行团体治疗； 3) 多中心 NIAAA COMBINE 研究，他是哈佛中心的 PI。作为 K24 奖的一部分，Weiss 博士将接受 1) 慢性疼痛、2) 脑成像和 3) 统计学领域的额外培训，这将同时增强他自己的研究技能并提高他的指导能力。